Author Correction: Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study

Diabetes Ther (2018) 9:613–621 https://doi.org/10.1007/s13300-018-0386-4 AUTHOR CORRECTION Author Correction: Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study Sarah J. Hallberg . Amy L. McKenzie . Paul T. Williams . Nasir H. Bhanpuri . Anne L. Peters . Wayne W. Campbell . Tamara L. Hazbun . Brittanie M. Volk . James P. McCarter . Stephen D. Phinney . Jeff S. Volek Published online: March 5, 2018 Ó The Author(s) 2018. This article is an open access publication Author Correction to: Diabetes Ther https://doi.org/10.1007/s13300-018-0373-9 The original version of this article unfortunately contained a mistake. The presentation of Table 1 and ESM 1 have been published incorrectly. Corrected units have been provided for LDL-C values. The corrected Table 1 in text is given below and ESM Table 1 is available online. The original article can be found online at https://doi. org/10.1007/s13300-018-0373-9. Electronic supplementary material The online version of this article (https://doi.org/10.1007/s13300018-0386-4) contains supplementary material, which is available to authorized users. S. J. Hallberg
T. L. Hazbun Medically Supervised Weight Loss, Indiana University Health Arnett, Lafayette, IN, USA W. W. Campbell Department of Nutrition Science, Purdue University, West Lafayette, IN, USA S. J. Hallberg
A. L. McKenzie (&)
N. H. Bhanpuri
B. M. Volk
J. P. McCarter
S. D. Phinney
J. S. Volek Virta Health, San Francisco, CA, USA e-mail: J. P. McCarter Department of Genetics, Washington University School of Medicine, St. Louis, MO, USA P. T. Williams Independent Consultant, Lafayette, CA, USA A. L. Peters Keck School of Medicine, University of Southern California, Los Angeles, CA, USA J. S. Volek Department of Human Sciences, The Ohio State University, Columbus, OH, USA Diabetes Ther (2018) 9:613–621 614 Table 1 Baseline characteristics of the recruited sample, completers, and participants with missing data by treatment arm All N Mean (SD) or – SE Completers with data Dropout or missing data Completers–dropouts N Mean – SE Mean (SD) or – SE N Mean (SD) or – SE Age (years) CCI-all educationa Usual care a CCI-all vs. usual careb 262 53.75 (8.35) 218 54.09 (8.35) 44 52.09 (8.25) 87 52.33 (9.52) 78 51.71 (9.62) 9 57.78 (6.85) 1.42 ± 1.14 2.38 ± 1.23* 2.0 ± 1.37 - 6.07 ± 2.53* - 5.69 ± 2.6* Female (%) CCI-all educationa Usual care a CCI-all vs. usual careb 262 66.79 ± 2.91 218 65.14 ± 3.23 87 58.62 ± 5.28 78 60.26 ± 5.54 8.17 ± 6.03 4.88 ± 6.41 44 75.0 ± 6.53 9 44.44 ± 16.56 - 9.86 ± 7.28 15.81 ± 17.47 30.56 ± 17.8 African American (%) CCI-all educationa Usual carea CCI-all vs. usual careb 262 6.87 ± 1.56 218 5.96 ± 1.6 87 0.0 ± 0.0 78 0.0 ± 0.0 6.87 ± 1.56§ 5.96 ± 1.6à 44 11.36 ± 4.78 9 0.0 ± 0.0 - 5.4 ± 5.05 0.0 ± 0.0 11.36 ± 4.78* Years with type 2 diabetes CCI-all educationa Usual carea CCI-all vs. usual careb 261 8.44 (7.22) 71 7.85 (7.32) 0.59 (0.9) 217 8.4 (7.28) 71 7.85 (7.32) 44 8.61 (6.97) - 0.21 ± 1.16 Not collected 0.56 ± 1.0 Beta-hydroxybutyrate (mmol L-1) CCI-all educationa Usual carea CCI-all vs. usual careb 248 0.17 (0.15) 186 0.17 (0.15) 62 0.19 (0.16) - 0.02 ± 0.02 79 0.15 (0.13) 59 0.14 (0.12) 20 0.17 (0.15) - 0.03 ± 0.03 0.02 ± 0.02 0.02 ± 0.02 0.02 ± 0.04 262 59.55 (16.4) 204 58.35 (15.3) Hemoglobin A1c (mmol mol-1) CCI-all educationa Usual carea 87 59.99 (19.24) 72 61.08 (19.89) 58 63.49 (19.57) - 28.66 ± 2.73 15 54.52 (14.87) - 16.97 ± 4.48 Diabetes Ther (2018) 9:613–621 615 Table 1 continued All N CCI-all vs. usual careb Mean (SD) or – SE - 0.44 ± 2.3 Completers with data Dropout or missing data Completers–dropouts N Mean – SE Mean (SD) or – SE - 2.73 ± 2.62 N Mean (SD) or – SE 8.96 ± 4.59* Hemoglobin A1c (%) CCI-all educationa Usual care a CCI-all vs. usual careb 262 7.60 (1.50) 87 7.64 (1.76) - 0.04 ± 0.21 204 7.49 (1.4) 72 7.74 (1.82) - 0.25 ± 0.24 58 7.96 (1.79) - 0.47 ± 0.25 15 7.14 (1.36) 0.60 ± 0.41 0.82 ± 0.42* Fasting glucose (mmol L-1) CCI-all educationa Usual carea CCI-all vs. usual careb 258 8.92 (3.41) 202 8.8 (3.28) 86 8.67 (4.03) 71 8.71 (3.96) 0.25 ± 0.48 0.1 ± 0.52 56 9.36 (3.83) - 0.55 ± 0.56 15 8.5 (4.5) 0.21 ± 1.25 0.86 ± 1.27 Insulin all (pmol L-1) CCI-all educationa Usual care a CCI-all vs. usual careb 248 198.35 (165.85) 186 197.65 (167.17) 79 202.17 (172.58) 59 206.68 (187.93) - 3.82 ± 22.09 - 9.1 ± 27.36 62 200.5 (163.21) - 2.85 ± 24.1 20 188.77 (119.18) 17.99 ± 36.18 11.74 ± 33.75 C-peptide (nmol L-1) CCI-all educationa Usual care a CCI-all vs. usual careb 247 1.45 (0.71) 185 1.47 (0.72) 62 1.39 (0.69) 0.07 ± 0.1 79 1.38 (0.82) 59 1.35 (0.82) 20 1.49 (0.84) - 0.14 ± 0.22 0.07 ± 0.1 0.12 ± 0.12 - 0.09 ± 0.21 HOMA-IR (insulin derived), all CCI-all educationa Usual care a CCI-all vs. usual careb 244 11.8 (13.14) 179 11.19 (12.75) 78 10.64 (9.12) 56 11.31 (10.05) 1.16 ± 1.33 - 0.12 ± 1.65 65 13.48 (14.12) - 2.3 ± 1.99 22 8.94 (6.03) 2.36 ± 1.86 4.54 ± 2.17 Diabetes Ther (2018) 9:613–621 616 Table 1 continued All N Mean (SD) or – SE Completers with data Dropout or missing data Completers–dropouts N Mean – SE Mean (SD) or – SE N Mean (SD) or – SE HOMA-IR (C-peptide derived) CCI-all educationa Usual care a CCI-all vs. usual careb 244 11.52 (7.15) 170 11.44 (6.26) 69 11.72 (9.04) - 0.28 ± 1.19 72 11.16 (7.26) 47 10.56 (7.70) 25 12.29 (6.33) - 1.73 ± 1.69 0.36 ± 0.97 0.88 ± 1.22 - 0.56 ± 1.67 Weight-clinic (kg) CCI-all educationa Usual carea CCI-all vs. usual careb 257 116.51 (25.94) 184 115.42 (24.62) 73 119.25 (29.01) - 3.83 ± 3.85 83 105.63 (22.15) 69 106.79 (22.18) 14 99.94 (21.86) 6.84 ± 6.42 10.87 ± 2.92§ 8.63 ± 3.23 19.3 ± 6.76 BMI (kg m-2) CCI-all educationa Usual care a CCI-all vs. usual careb 257 40.43 (8.81) 184 39.87 (7.88) 73 41.82 (10.75) - 1.94 ± 1.39 83 36.72 (7.26) 69 37.14 (7.62) 14 34.66 (4.8) 2.48 ± 1.58 3.7 ± 0.97à 2.73 ± 1.09 7.15 ± 1.8§ Systolic blood pressure (mmHg) CCI-all educationa Usual care a CCI-all vs. usual careb 260 131.94 (14.09) 187 132.51 (14.54) 73 130.47 (12.84) 2.05 ± 1.84 79 129.8 (13.61) 67 128.72 (12.65) 12 135.83 (17.49) - 7.12 ± 5.28 2.14 ± 1.76 3.8 ± 1.88* - 5.37 ± 5.27 Diastolic blood pressure (mmHg) CCI-all educationa Usual care a CCI-all vs. usual careb 260 82.09 (8.25) 187 81.59 (8.05) 73 83.37 (8.67) - 1.78 ± 1.17 79 82.0 (8.93) 67 81.1 (8.07) 12 87.0 (11.95) - 5.9 ± 3.59 0.09 ± 1.13 0.49 ± 1.15 247 4.76 (1.07) 186 4.68 (1.03) 61 4.99 (1.15) - 0.31 ± 0.17 79 4.76 (1.19) 59 4.72 (1.26) 20 4.88 (0.93) - 0.16 ± 0.27 - 3.63 ± 3.6 Total cholesterol (mmol L-1) CCI-all educationa Usual care a Diabetes Ther (2018) 9:613–621 617 Table 1 continued All N CCI-all vs. usual careb Mean (SD) or – SE - 0.0 ± 0.15 Completers with data Dropout or missing dat (...truncated)